Shared on04 Oct 25Fair value Increased 0.21%
Aflac's analyst price target has been raised slightly, with an increase of $2 to $108. Analysts highlight strong Q2 sales driven by new product rollouts and improved net interest income.
Shared on30 Apr 25Fair value Increased 2.28%
AnalystConsensusTarget has decreased shares outstanding growth rate from -0.0% to -0.0%.
Shared on23 Apr 25Fair value Increased 0.042%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on16 Apr 25Fair value Decreased 0.68%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Increased 0.89%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 9.78%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25Fair value Decreased 2.12%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.